Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14

Eur Urol. 2017 Sep;72(3):e74-e75. doi: 10.1016/j.eururo.2017.01.013. Epub 2017 Jan 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • Carcinoma, Renal Cell*
  • Everolimus*
  • Genomics
  • Humans
  • Indoles
  • Kidney Neoplasms
  • Pyrroles
  • Sunitinib

Substances

  • Biomarkers
  • Indoles
  • Pyrroles
  • Everolimus
  • Sunitinib